Figure 2.
Impact of ranolazine vs placebo on angina equivalents in patients with coronary microvascular dysfunction: (A) angina frequency; (B) physical functioning; (C) angina stability; (D) treatment satisfaction; and (E) quality of life. CI, confidence interval; IV, weighted mean difference; SE, standard error; SD, standard deviation.